Written and maintained by CASRAI Editorial Board
Last updated
Reader task: Hospital pharmacists, clinical informatics architects, and clinical trial investigators searching for lexicomp or lexidrug need to understand the clinical modules inside UpToDate Lexidrug (formerly Lexicomp), interpret its Lexi-Interact A–X risk scale and Trissel’s IV compatibility database, and distinguish its referential EHR workflow from embedded drug databases.
Informational notice: This guide examines the software architecture, database modules, and health informatics standards of Lexicomp (UpToDate Lexidrug) for research and clinical systems practice; it does not provide medication dosing or patient treatment advice.
What is Lexicomp (UpToDate Lexidrug)?
Lexicomp—formally rebranded by Wolters Kluwer Health as UpToDate Lexidrug—is an evidence-based referential drug information and clinical decision support (CDS) platform used by health-system pharmacists, physicians, advanced practice providers, nurses, and clinical researchers. Designed for point-of-care medication verification, formulary governance, and pharmacy informatics, the platform consolidates peer-reviewed drug monographs, intravenous (IV) admixture compatibility matrices, drug-interaction screening, pharmacogenomic (PGx) annotations, and clinical calculators into web, mobile, and EHR-embedded interfaces (for academic citation rules, see How to Reference Lexicomp).
Who runs it and what it covers
Developed and maintained by the Clinical Effectiveness division of Wolters Kluwer Health, UpToDate Lexidrug is aligned editorially with UpToDate (point-of-care clinical synopses) and Medi-Span (embedded machine-readable drug data files). Its core database modules cover:
- Comprehensive Drug Monographs (Lexi-Drugs): Point-of-care monographs detailing FDA-approved and off-label indications, mechanism of action, pharmacodynamics and pharmacokinetics (ADME), boxed warnings, adverse reactions stratified by incidence percentage, contraindictions, renal and hepatic organ-impairment considerations, and international brand-name cross-references.
- Population-Specific Databases (Pediatric & Neonatal Lexi-Drugs, Geriatric Lexi-Drugs): Dedicated monograph sets tailored for gestational and postnatal age groups in neonatal intensive care units (NICUs) and pediatric wards, as well as geriatric Beers Criteria precautions.
- Trissel’s 2 Clinical Pharmaceutics Database (IV Compatibility): Built upon Lawrence A. Trissel’s parenteral stability reference, this module evaluates physical and chemical compatibility for Y-site co-administration, syringe mixing, and bag admixtures across multi-lumen central and peripheral IV infusions.
- Lexi-Interact (Lexicomp Drug Interactions): Multi-agent interaction engine analyzing drug-drug, drug-herb, drug-food, drug-ethanol, and duplicate-therapy interactions.
- Pharmacogenomics (PGx), Toxicology (Lexi-Tox), and AHFS Integration: Incorporates Clinical Pharmacogenetics Implementation Consortium (CPIC) and FDA biomarker guidance alongside optional American Society of Health-System Pharmacists (ASHP) AHFS Drug Information content sets.
How to search and use Lexicomp in clinical and research workflows
According to Wolters Kluwer’s official UpToDate Lexidrug documentation, clinicians and research pharmacists navigate the platform’s core clinical tools through six structured interface workflows:
- Monograph Search and Jump-To Navigation: Users query the search bar by generic name (USAN/INN), brand name, NDC code, or pharmacologic class. Opening a monograph displays a left-hand Jump-To outline panel (covering sections such as Warnings/Precautions, Adverse Reactions, Metabolism/Transport Effects, Administration, and Monitoring Parameters) alongside institution-specific Formulary Status badges when integrated with a hospital’s pharmacy system.
- Running a Lexicomp Drug Interactions Check (Lexi-Interact): Selecting the Interactions tool from the top navigation bar allows users to enter a patient’s full list of active medications, investigational study comparators, and dietary supplements. The engine outputs pairwise interaction alerts ranked by the five-level Lexi-Interact Risk Rating:
- Risk Rating X (Avoid Combination): Data demonstrate that the specified agents may interact with each other in a clinically significant manner; the risks associated with concomitant use usually outweigh the benefits.
- Risk Rating D (Consider Therapy Modification): Data demonstrate that the two medications may interact in a clinically significant manner; a patient-specific assessment is required to determine whether to modify therapy or intensify monitoring.
- Risk Rating C (Monitor Therapy): Data demonstrate that the specified agents may interact with each other in a clinically significant manner, but the benefits of concomitant use usually outweigh the risks with an appropriate monitoring plan.
- Risk Rating B (No Action Needed): Data demonstrate that the specified agents may interact with each other, but there is little to no evidence of clinical concern resulting from their concomitant use.
- Risk Rating A (No Known Interaction): Data have not demonstrated either pharmacodynamic or pharmacokinetic interactions between the specified agents.
- Evaluating Parenteral Stability in Trissel’s IV Compatibility: Selecting the IV Compatibility tab allows critical care nurses and research pharmacists to input two or more parenteral drugs and diluents (such as 0.9% Sodium Chloride or D5W). The matrix displays color-coded compatibility results—Compatible (C), Incompatible (I), Uncertain/Variable (U), or No Data—across Y-site, admixture, and syringe columns, with direct links to concentration limits, storage temperatures, and primary stability study citations.
- Drug ID (Solid Oral Dosage Identification): Entering tablet or capsule imprint codes, shape, color, and scoring in the Drug ID tool identifies unknown home medications during clinical trial screening or hospital medication reconciliation.
- Clinical Calculators and Creatinine Clearance Estimation: Built-in clinical calculators support pharmacokinetic and organ-function equations, cross-linked directly from the renal and hepatic impairment sections of individual monographs.
- EHR Launch via HL7 Infobutton: Inside enterprise EHRs such as Epic Systems (Hyperspace/Willow), Oracle Health, and MEDITECH, clicking the embedded drug-reference icon next to an active medication order invokes the HL7 Context-Aware Knowledge Retrieval (Infobutton) Standard, passing the medication’s RxNorm or NDC identifier, patient age group, and clinical context directly to UpToDate Lexidrug to open the exact monograph section without re-typing the drug name.
Strengths and limits
- Strengths: Concise, point-of-care bulleted monograph layout optimized for rapid clinical lookup; transparent A–X interaction risk ratings paired with severity and evidence-reliability scores; industry-standard Trissel’s IV compatibility integration; seamless synchronization with UpToDate clinical topics and Medi-Span EHR order-entry data.
- Limits: Primarily a clinical referential database rather than a wholesale pharmaceutical pricing or reimbursement benchmark book (unlike Micromedex RED BOOK, which focuses on AWP/WAC pricing, or the WHO Drug Dictionary, which standardizes global pharmacovigilance coding in clinical trial safety databases).
Alternatives to Lexicomp compared
Hospital pharmacy and therapeutics (P&T) committees, academic medical libraries, and clinical informatics teams typically evaluate UpToDate Lexidrug alongside three major drug information platforms:
| Platform | Publisher | Core Clinical & Informatics Modules | Primary Healthcare & Research Strength |
|---|---|---|---|
| UpToDate Lexidrug (Lexicomp) | Wolters Kluwer Health | Lexi-Drugs (Adult, Pediatric/Neonatal, Geriatric), Trissel’s 2 IV Compatibility, Lexi-Interact (A–X scale), PGx | Rapid point-of-care referential monographs, NICU/pediatric depth, and tight integration with UpToDate and Medi-Span in Epic/Oracle EHRs. |
| Merative Micromedex (including RED BOOK) | Merative (formerly IBM Watson Health / Truven) | DrugDex in-depth literature monographs, NeoFax, Pediatrics, Trissel’s IV compatibility, POISINDEX toxicology, RED BOOK pricing | Exhaustive primary-literature citations in DrugDex, poison control center toxicology (POISINDEX), and NDC drug pricing (RED BOOK). |
| DynaMedex | EBSCO Information Services & ASHP | Combines DynaMed disease topic synopses with ASHP AHFS Drug Information monographs and drug interaction tools | Unified disease-and-drug point-of-care interface built on ASHP’s authoritative AHFS compendia. |
| Clinical Pharmacology | Elsevier | Point-of-care drug monographs, IV compatibility, multi-drug interaction checker, and Gold Standard drug database | Real-time FDA label updates and integration with Elsevier ClinicalKey and Gold Standard pharmacy data files. |
Frequently asked questions
What is Lexicomp and why is it now called UpToDate Lexidrug?
Lexicomp—rebranded by Wolters Kluwer Health as UpToDate Lexidrug—is an evidence-based referential clinical drug information and point-of-care medication decision-support platform. It provides adult, pediatric, neonatal, and geriatric drug monographs, Trissel’s 2 IV compatibility tables, Lexi-Interact drug interaction screening (scored on an A-through-X risk scale), and pharmacogenomic guidance integrated into hospital EHRs.
How does Lexicomp evaluate drug interactions?
Through its Lexi-Interact module, Lexicomp (UpToDate Lexidrug) analyzes multi-drug regimens—including prescription drugs, over-the-counter medications, herbals, foods, and ethanol—and assigns each pair a five-tier Risk Rating: A (No known interaction), B (No action needed), C (Monitor therapy), D (Consider therapy modification), or X (Avoid combination), supported by severity and evidence reliability ratings.
How does Lexicomp differ from Medi-Span inside an EHR?
Both belong to Wolters Kluwer’s clinical drug suite and share a synchronized editorial foundation, but they serve different technical layers: UpToDate Lexidrug (Lexicomp) delivers human-readable referential drug monographs, calculators, and IV compatibility charts at the point of care (often launched via HL7 Infobutton), while Medi-Span supplies the structured, machine-readable drug data files (NDC, RxNorm, GPI codes) embedded directly into computerized provider order entry (CPOE) and pharmacy dispensing engines.
